Systemic therapy escalation after stereotactic body radiation therapy for oligometastatic hormone-sensitive prostate cancer

PURPOSE: To evaluate the oncological outcome after stereotactic body radiation therapy (SBRT) for oligometastatic hormone-sensitive prostate cancer (omHSPC) patients. MATERIALS-METHODS: In this retrospective, observational, multi-institutional study, omHSPC patients (≤5 metastases) underwent SBRT. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Baron, D., Pasquier, D., Pace-Loscos, T., Vandendorpe, B, Schiappa, R., Ortholan, C., Hannoun-Levi, J.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493250/
https://www.ncbi.nlm.nih.gov/pubmed/37701481
http://dx.doi.org/10.1016/j.ctro.2023.100673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493250/
https://www.ncbi.nlm.nih.gov/pubmed/37701481
http://dx.doi.org/10.1016/j.ctro.2023.100673

Ejemplares similares